As­traZeneca flesh­es out piv­otal da­ta on $930M rare blood dis­or­der drug it wants to pair with Soliris, Ul­tomiris

As­traZeneca says its add-on pill for a rare blood dis­or­der known as parox­ys­mal noc­tur­nal he­mo­glo­bin­uria, or PNH, helped pa­tients al­ready tak­ing Ul­tomiris or Soliris pro­duce …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER